PROVIDER PROFILE · NPI 1881833101

Christine HoogasianNP

Nurse PractitionerWorcester, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

379

Unique beneficiaries

—

Total services

608

Distinct HCPCS

Medicare payment

$36K

Peer benchmark

Total Medicare services vs. 5,906 Nurse Practitioner providers in MA — above median (cohort median 289).

PRESCRIBING · PART D · 2024

Total Rx claims

7,858

Beneficiaries

—

Total drug cost

$3.5M

Distinct drugs

Brand share

73.2%

Top prescribed drugs

Dulaglutide645 claims

Semaglutide602 claims

Metformin Hcl599 claims

Empagliflozin519 claims

Insulin Glargine,hum.Rec.Anlog409 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

83.0

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$354

Payment records

By payment type

Food and Beverage$354

REFERRAL NETWORK

Where Christine Hoogasian's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA	75	244
Samir Malkani Endocrinology · Worcester, MA	28	92
Pang-Yen Fan Nephrology · Worcester, MA	19	202
UMASS MEMORIAL HEALTHALLIANCE CLINTON HOSPITAL INC	14	60
Asem Ali Endocrinology · Boston, MA	12	24
KHER, AJAY	12	78

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history